Judith A. Varner

12.9k total citations · 6 hit papers
82 papers, 9.2k citations indexed

About

Judith A. Varner is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Judith A. Varner has authored 82 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 36 papers in Immunology and Allergy and 32 papers in Oncology. Recurrent topics in Judith A. Varner's work include Cell Adhesion Molecules Research (36 papers), Angiogenesis and VEGF in Cancer (31 papers) and Immune cells in cancer (22 papers). Judith A. Varner is often cited by papers focused on Cell Adhesion Molecules Research (36 papers), Angiogenesis and VEGF in Cancer (31 papers) and Immune cells in cancer (22 papers). Judith A. Varner collaborates with scholars based in United States, South Korea and Italy. Judith A. Varner's co-authors include David A. Cheresh, Barbara Garmy‐Susini, Christie J. Avraamides, Semi Kim, Paulina Pathria, Tiani L. Louis, Hua Jin, Peter C. Brooks, Michael C. Schmid and R. L. Juliano and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Judith A. Varner

78 papers receiving 9.1k citations

Hit Papers

Definition of Two Angiogenic Pathways by Distinct α v Int... 1995 2026 2005 2015 1995 2008 2019 2000 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Definition of Two Angiogenic Pathways by Distinct α v Integrins
    1995 1.1k citations Judith A. Varner, David A. Cheresh et al. Science profile →
  2. Integrins in angiogenesis and lymphangiogenesis
    2008 826 citations Christie J. Avraamides, Barbara Garmy‐Susini et al. profile →
  3. Targeting Tumor-Associated Macrophages in Cancer
    2019 723 citations Paulina Pathria, Tiani L. Louis et al. Trends in Immunology profile →
  4. Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin
    2000 519 citations Semi Kim, Judith A. Varner et al. profile →
  5. Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
    2015 381 citations Andrew J. Gunderson, Megan M. Kaneda et al. Cancer Discovery profile →
  6. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
    2024 77 citations Jaroslav Žák, Brett S. Marro et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith A. Varner United States 44 4.7k 3.3k 2.8k 2.5k 1.7k 82 9.2k
Kairbaan Hodivala‐Dilke United Kingdom 50 5.3k 1.1× 3.2k 1.0× 2.0k 0.7× 1.4k 0.5× 1.6k 1.0× 107 9.7k
Dwayne G. Stupack United States 46 4.4k 0.9× 2.3k 0.7× 1.5k 0.5× 995 0.4× 1.2k 0.7× 109 7.3k
M. Sharon Stack United States 55 5.2k 1.1× 1.9k 0.6× 3.3k 1.2× 1.2k 0.5× 4.0k 2.4× 192 10.4k
Ulla M. Wewer Denmark 58 6.1k 1.3× 3.6k 1.1× 2.6k 0.9× 1.2k 0.5× 2.3k 1.3× 136 11.0k
Margot Zöller Germany 53 8.1k 1.7× 2.4k 0.7× 3.1k 1.1× 3.1k 1.2× 3.3k 1.9× 197 13.2k
Kristiina Vuori United States 44 5.5k 1.2× 3.7k 1.1× 1.5k 0.5× 1.3k 0.5× 1.4k 0.8× 81 9.0k
Clare M. Isacke United Kingdom 57 4.9k 1.0× 1.3k 0.4× 2.5k 0.9× 1.2k 0.5× 1.8k 1.1× 141 8.5k
Carlos Cabañas Spain 43 2.7k 0.6× 2.6k 0.8× 887 0.3× 2.1k 0.8× 1.0k 0.6× 101 6.2k
Goos N.P. van Muijen Netherlands 47 3.1k 0.6× 1.5k 0.4× 2.5k 0.9× 1.9k 0.7× 1.3k 0.8× 125 6.9k
Edwin Clark United States 30 4.1k 0.9× 2.6k 0.8× 2.5k 0.9× 747 0.3× 1.7k 1.0× 61 8.4k

Countries citing papers authored by Judith A. Varner

Since Specialization
Citations

This map shows the geographic impact of Judith A. Varner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A. Varner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A. Varner more than expected).

Fields of papers citing papers by Judith A. Varner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A. Varner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A. Varner. The network helps show where Judith A. Varner may publish in the future.

Co-authorship network of co-authors of Judith A. Varner

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A. Varner. A scholar is included among the top collaborators of Judith A. Varner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A. Varner. Judith A. Varner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žák, Jaroslav & Judith A. Varner. (2025). Positive and negative roles of myeloid cells in cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 13(10). e012743–e012743.
2.
Žák, Jaroslav, Brett S. Marro, Kristi Marquardt, et al.. (2024). JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science. 384(6702). eade8520–eade8520. 77 indexed citations breakdown →
3.
Wettersten, Hiromi I., Sara M. Weis, Paulina Pathria, et al.. (2019). Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression. Cancer Research. 79(19). 5048–5059. 25 indexed citations
4.
Pathria, Paulina, Tiani L. Louis, & Judith A. Varner. (2019). Targeting Tumor-Associated Macrophages in Cancer. Trends in Immunology. 40(4). 310–327. 723 indexed citations breakdown →
5.
Foubert, Philippe, Megan M. Kaneda, & Judith A. Varner. (2017). PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression. Cancer Immunology Research. 5(11). 957–968. 69 indexed citations
6.
Kaneda, Megan M., Paola Cappello, Abraham V. Nguyen, et al.. (2016). Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression. Cancer Discovery. 6(8). 870–885. 236 indexed citations
7.
Gunderson, Andrew J., Megan M. Kaneda, Takahiro Tsujikawa, et al.. (2015). Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer. Cancer Discovery. 6(3). 270–285. 381 indexed citations breakdown →
8.
McCabe, Katelyn E., Alena Bartáková, Joe R. Delaney, et al.. (2015). Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma. PLoS ONE. 10(5). e0120815–e0120815. 22 indexed citations
9.
Schmid, Michael C., Irene Franco, Sang Won Kang, et al.. (2013). PI3-Kinase γ Promotes Rap1a-Mediated Activation of Myeloid Cell Integrin α4β1, Leading to Tumor Inflammation and Growth. PLoS ONE. 8(4). e60226–e60226. 58 indexed citations
10.
Schmid, Michael C., Christie J. Avraamides, Philippe Foubert, et al.. (2011). Combined Blockade of Integrin-α4β1 Plus Cytokines SDF-1α or IL-1β Potently Inhibits Tumor Inflammation and Growth. Cancer Research. 71(22). 6965–6975. 96 indexed citations
11.
Garmy‐Susini, Barbara, Christie J. Avraamides, Michael C. Schmid, et al.. (2010). Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis. Cancer Research. 70(8). 3042–3051. 134 indexed citations
12.
Garmy‐Susini, Barbara & Judith A. Varner. (2008). Roles of Integrins in Tumor Angiogenesis and Lymphangiogenesis. Lymphatic Research and Biology. 6(3-4). 155–163. 79 indexed citations
13.
Jin, Hui, Jingmei Su, Barbara Garmy‐Susini, Jeanine Kleeman, & Judith A. Varner. (2006). Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors. Cancer Research. 66(4). 2146–2152. 109 indexed citations
14.
Garmy‐Susini, Barbara & Judith A. Varner. (2005). Circulating endothelial progenitor cells. British Journal of Cancer. 93(8). 855–858. 71 indexed citations
15.
Jin, Hua & Judith A. Varner. (2004). Integrins: roles in cancer development and as treatment targets. British Journal of Cancer. 90(3). 561–565. 440 indexed citations
16.
Kim, Semi, Manjiri M. Bakre, Hong Yin, & Judith A. Varner. (2002). Inhibition of endothelial cell survival and angiogenesis by protein kinase A. Journal of Clinical Investigation. 110(7). 933–941. 128 indexed citations
17.
Kim, Semi, et al.. (2002). Inhibition of endothelial cell survival and angiogenesis by protein kinase A. Journal of Clinical Investigation. 110(7). 933–941. 6 indexed citations
18.
Aoka, Yoshikazu, Frances L. Johnson, Kalyani Penta, et al.. (2002). The Embryonic Angiogenic Factor Del1 Accelerates Tumor Growth by Enhancing Vascular Formation. Microvascular Research. 64(1). 148–161. 69 indexed citations
19.
Penta, Kalyani, et al.. (1999). Del1 Induces Integrin Signaling and Angiogenesis by Ligation of αVβ3. Journal of Biological Chemistry. 274(16). 11101–11109. 125 indexed citations
20.
Varner, Judith A. & David A. Cheresh. (1996). Integrins and cancer. Current Opinion in Cell Biology. 8(5). 724–730. 419 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kairbaan Hodivala‐Dilke Breakdown of academic impact, for papers by Dwayne G. Stupack Breakdown of academic impact, for papers by M. Sharon Stack Breakdown of academic impact, for papers by Ulla M. Wewer Breakdown of academic impact, for papers by Margot Zöller Breakdown of academic impact, for papers by Kristiina Vuori Breakdown of academic impact, for papers by Clare M. Isacke Breakdown of academic impact, for papers by Carlos Cabañas Breakdown of academic impact, for papers by Goos N.P. van Muijen Breakdown of academic impact, for papers by Edwin Clark
Rankless by CCL
2026